Alliance of Infinity Trade
Rabeprazole sodium
Introducing AIT Pharmaceuticals Division’s Rabeprazole Sodium Tablets
At AIT Pharmaceuticals Division, we are dedicated to advancing healthcare by providing high-quality pharmaceutical solutions. Our Rabeprazole Sodium Tablets exemplify our commitment to delivering effective treatments for gastrointestinal disorders. Rabeprazole sodium, the active ingredient in our tablets, is a proton pump inhibitor (PPI) renowned for its potent acid-suppressing properties.
Share
Drug Classification: Rabeprazole sodium belongs to the class of proton pump inhibitors (PPIs), which work by irreversibly inhibiting the hydrogen-potassium adenosine triphosphatase enzyme system in the gastric parietal cells, thereby reducing gastric acid secretion.
Formulation:
- Rabeprazole Sodium Tablets: Each tablet contains 40mg of rabeprazole sodium, ensuring optimal dosing for patients with acid-related disorders.
Indications:
Rabeprazole sodium tablets are indicated for the:
- Treatment of gastroesophageal reflux disease (GERD), including erosive esophagitis.
- Maintenance of healing of erosive esophagitis.
- Treatment of duodenal ulcers and gastric ulcers.
- Reduction of risk of gastric ulcers associated with nonsteroidal anti-inflammatory drugs (NSAIDs) in patients at risk.
Pharmacokinetics:
- Absorption: Rabeprazole sodium is rapidly absorbed after oral administration, with peak plasma concentrations achieved within 1-2 hours.
- Distribution: It is extensively distributed throughout the body, including the gastrointestinal tract.
- Metabolism: Rabeprazole sodium undergoes hepatic metabolism via the cytochrome P450 enzyme system, primarily by CYP2C19 and CYP3A4.
- Elimination: The elimination half-life of rabeprazole sodium is approximately 1-2 hours, with the majority of the drug excreted in the urine as metabolites.
Pharmacodynamics:
Rabeprazole sodium inhibits the proton pump in the gastric parietal cells, resulting in a profound and prolonged suppression of gastric acid secretion. This mechanism of action provides effective relief from symptoms of acid-related disorders and promotes healing of damaged mucosa.
Usage:
- Rabeprazole sodium tablets should be taken orally, usually once daily, with or without food.
Dosage:
- The recommended dosage of rabeprazole sodium for adults varies depending on the indication and severity of the condition.
- For the treatment of GERD and maintenance of healing of erosive esophagitis, the usual dose is 20mg or 40mg once daily for up to 8 weeks.
Side Effects:
- Common side effects of rabeprazole sodium may include:
- Headache
- Nausea
- Abdominal pain
- Diarrhea
- Flatulence
- Serious side effects such as Clostridium difficile-associated diarrhea and hypomagnesemia may occur but are rare.
Experience the efficacy and reliability of AIT Pharmaceuticals Division’s Rabeprazole Sodium Tablets in the management of acid-related disorders. For more information, please contact us.
Reviews
There are no reviews yet.